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Abstract
X-ray crystal structure determination of agglutinin from abrus precatorius in Taiwan is presented. The crystal structure of 
agglutinin, a type II ribosome-inactivating protein (RIP) from the seeds of Abrus precatorius in Taiwan, has been 
determined from a novel crystalline form by the molecular replacement method using the coordinates of abrin-a as 
the template. The structure has space group P41212 with Z = 8, and been refined at 2.6 Å to R-factor of 20.4%. The root-
mean-square deviations of bond lengths and angles from the standard values are 0.009 Å and 1.3°. Primary, secondary, 
tertiary and quaternary structures of agglutinin have been described and compared with those of abrin-a to a certain 
extent. In subsequent docking research, we found that Asn200 of abrin-a may form a critical hydrogen bond with 
G4323 of 28SRNA, while corresponding Pro199 of agglutinin is a kink hydrophobic residue bound with the cleft in a 
more compact complementary relationship. This may explain the lower toxicity of agglutinin than abrin-a, despite of 
similarity in secondary structure and the activity cleft of two RIPs.
Background
Ribosome inactivating proteins (RIPs) are enzymes that
can inactivate ribosomes. The molecular mechanism of
inhibitory effect on protein synthesis has been shown
that RIPs act as a RNA N-glycosidase hydrolyzing the C-
N glycosidic bond of the adenosine residue at position
4324 in rat 28S rRNA [1,2]. They can cleave the synthetic
RNA structure having a short double-helical stem and a
loop containing a centered GAGA sequence, the first A
being the cleavage site [3]. The depurination inactivates
the ribosomes for binding to elongation factor 2 catalyz-
ing GTP hydrolysis and translocation of peptidyl-tRNA
to the P site [4], with a consequence inhibiting the protein
synthesis. There are three categories of RIPs according to
the physical composition and characteristics. Most com-
monly RIPs are type I RIPs, only single polypeptide chain
proteins composed of the toxophoric A subunit with a
molecular mass around 30 kDa [5-8] such as curcin [9]
and trichomislin [10]. Some are type II RIPs consisting of
two types of polypeptide subunits, A chain of homolo-
gous and functionally similar to type I RIPs and B chain
with a galactose-specific lectin domain that binds to cell
surfaces, such as ricin [11] abrin and abrus agglutinin
(AAG) [12]. A chain and B chain are from one gene and
link through disulfide bond after post-translation modifi-
cation [13]. Type III RIPs are derived from inactive pro-
protein and activated after proteolysis [14]. The mature
type III RIPs are two polypeptide subunits acting as an N-
glycosidase jointly.
Various RIPs can be isolated from the same plants
[15,16]. Some type II RIPs have been isolated from the
beans of the tropical and subtropical leguminous plant
Abrus precatorius, jequirity. They are lectins and have an
inhibitory effect on the growth of experimental animal
tumors [17,18]. They can be classified as abrins and AAG
by oligomerization. Abrins are potent toxic heterodi-
meric glycoproteins with an LD50 of 20 μg/kg body
weight; while AAG is a relatively less toxic heterotetra-
meric glycoprotein of which the LD50 is 5 mg/kg body
weight [12]. But their therapeutics indexes are similar
[18].
The primary structures of abrin-a and AAG were deter-
mined [19-21]. AAG had high homology to the extremely
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toxic ABRa, with 44 (8.0%) similar amino acid residues
and 382 (69.8%) invariant amino acid residues. In the A
chain of AAG, the 13 amino acid residues with catalytic
function among RIPs were completely conserved [21].
The cDNAs of the RIPs isolated from Abrus precatorius
have been cloned and their A chains were expressed in
Escherichia. coli [21-23]. The amino acid residues at pro-
posed active sites and Pro199 of AAG, which correspond-
ing to Asn200 of abrin-a, were analyzed with site-directed
mutagenesis for studying the structure and function of
these RIPs [21,23,24]. And the results showed that Pro199
in A- (or C-) chain of AAG impair the activity of protein
synthesis inhibition because of steric hindrance [21].
According to the biochemical experiments, the mutation
of Asn200 on abrin a-chain to Pro200 dramatically
decreases the activity than other kind of mutation,
including those residues without side-chain, such as Gly
[23,24]. These peculiar results motivate us to crystallize
AAG, and make comparison with abrin, since both con-
tains almost identical active pocket, and most important
of all, different at Asn200 (the corresponding residue is
on AAG Pro199). Bagaria et al., [25] reported a 3.5 Å X-
ray crystal structure, and proposed the less toxic nature is
because of the fewer interactions involved with the sub-
strate adenine.
Bagaria et al., [25] assigned their low resolution of AAG
crystal to belong to the space group of P42212, instead of
our present and previous P41212 [26], to analyze the crys-
tal structure based on a mixture of indigenous and alien
data. They crystallized their Indian AAG material in a
condition similar to, but different from ours [25,26].
Strange to us, they did not determine their own Indian
AAG amino acid sequence, but adopted the Taiwanese
primary structure [21,25]. Indian AAG molecular pack-
ing may be different from our Taiwanese that could man-
ifest itself some way in different space group. Although
they published the controversial paper of 60 kDa struc-
ture in advance [25], this detail worthwhile work of more
complicated and precise 120 kDa heterotetramer aggluti-




AAG was isolated from the kernels of Abrus precatorius
seeds by chromatographies on a Sepharose 6B column
and a Sephadex G-100 column as described previously
[12]. The flow rate of chromatography was 20 ml/hr and
protein concentration was determined by the bicinchonic
acid method [27]. The kernels of 200 g were soaked in 5%
cold acetic acid of 1 L overnight and homogenized. After
centrifuging at 10,000 g at 4°C for 15 mins, the superna-
tant was collected for subsequently subjecting to the
ammonium sulfate fraction between 35 and 90 and then
centrifuging at 10,000 g at 4°C for 20 mins. The precipi-
tate was collected for dialysis against cold 10 mM sodium
phosphate buffer, pH 8 at 4°C. The dialysis buffer was
changed every 8 hrs for more than 2 days. The superna-
tant of dialysate was centrifuged at 17,800 g at 4°C for 20
mins and then applied on a Sepharose 6B affinity column
(3.0 × 50 cm) pre-equilibrated and washed with 10 mM
sodium phosphate buffer, pH 8. The eluent constiting of
abrins and AAG were obtained with the elution buffer,
the wash buffer containing 100 mM D-galactose. Then
the precipitate was obtained from the eluent subjected to
90% ammonium sulfate and dialyzed and centrifuged as
mentioned above. The supernatant was loaded onto gel
filtration on Sephadex G-100 column (2.2 × 100 cm) with
10 mM sodium phosphate buffer, pH 8. Two major peaks
can be observed and the fractions of AAG, corresponding
to the first peak, were pooled and lyophilized.
Crystallization
The formula for crystallization was described in our pre-
vious paper [26]. Crystals suitable for X-ray analysis were
obtained by the sitting drop vapor-diffusion method at
room temperature (297 (2) K) [28]. 8 μl of protein solu-
tion at a concentration of 10 mg/ml prepared from lyo-
philized protein was mixed with 8 μl of reservoir solution
containing PEG 8000; the precipitant condition was 0.1
M Tris pH 7.5 with 6.5% PEG 8000 plus 1% sodium azide
and crystals appeared after nearly four months.
Data Collection
X-ray Data were collected with a crystal of dimensions
0.30 × 0.30 × 0.25 mm that was mounted in a cryo-loop
manufactured by Hampton Research. After immersed in
the cryo-protectant of 20% glycerol and 80% mother
liquor for several seconds, the cryo-loop was mounted on
goniometer head inside liquid nitrogen stream at 100 K.
X-ray diffraction was measured with CCD (ADSC Quan-
tum-Q4R CCD Area Detector), on 1 D synchrotron radi-
ation X-ray (SPring-8 Taiwan Contract Beam-line
BL12B2 of NSRRC). The crystal-to-detector distance was
215 mm. The space group and unit-cell parameters were
determined from the well resolved diffraction spots. The
data were processed using the programs HKL2000 [29].
The agglutinin crystal belongs to the tetragonal system,
with unit-cell parameters a = b = 137.05, c = 214.42 Å, V
= 4.0275 × 106 Å3, Z = 8. A 99.1% complete dataset to 2.47
Å resolution of 73,976 unique reflections was collected
with averaged Rsym of 7.2%, averaged χ2 of 1.153, averaged
I/σ of 11.89, and redundancy of 4.1.
Determination of space group and initial phase
The systematic absences, l = 4n + 1, 2, 3 for 00l reflec-
tions, and h = 2n + 1 for h00 reflections, indicate thatCheng et al. Journal of Biomedical Science 2010, 17:34
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there are two possible space groups, namely P41212 or
P43212. The ambiguity of space group was solved together
with the initial phase problem by molecular replacement
method using version 1.1 of CNS program [30] with the
coordinates of abrin-a [31] as model. An X-ray diffraction
data shell from 4 to 15 Å was used for the calculation of
the cross rotation function with CNS program [32]. The
highest two were corresponding to a rotation of the
model by the rotation angel of θ1 = 37.9E, θ2 = 39.6E, θ3
= 342.1E, and θ1 = 358.1E, θ2 = -0.5E, θ3 = 2.4E in the
space group of P41212. After translation searches with
CNS program [33] according to these two rotation
angles, the initial model of AB- and CD-chains of aggluti-
nin was established.
Crystallographic Refinement
Structural refinement were performed in the following
iteration steps: rigid body refinement [34], simulated
annealing [35] of residue coordinates, group B factor
refinement [34], density modification [36], manual
manipulation using O program [37], and energy minimi-
zation [38]. The crystal data and R factor are listed in
Table 1. The final R factor using all reflections in the reso-
lution range 2.6 to 30 Å is 20.4%, while Rfree using ran-
domly selected 10% reflections which were excluded from
refinement is 23.6%. The Ramachandran plot including
A-, B-, C-, and D-chains is acceptable as shown in Table 1.
Docking
The program SPHGEN identifies the active site, and
other sites of interest, and generates the sphere centers
that fill the site. It has been described in the original
paper [39]. The program GRID generates the scoring
grids [40,41]. Within the DOCK suite of programs, the
program DOCK matches spheres (generated by SPH-
G E N)  w i t h  l i g a n d  a t o m s  a n d  u s e s  s c o r i n g  g r i d s  ( f r o m
GRID) to evaluate ligand orientations [38,39]. Program
DOCK also minimizes energy based scores [42]. Parame-
ters used in DOCK were modified from the paper of pro-
tein docking and complementary principle [43].
The atomic coordinates of the refined agglutinin struc-
ture and the reflection data have been deposited with the
Protein Data Bank in Japan. The accession numbers for
these atomic coordinates are (PDB ID) 2ZR1and
(RCSB ID) RCSB028317.
Results and Discussion
As shown in figure 1, the AAG AB-chains are very similar
to the abrin-a molecule, the structure of which has been
described in detail [31]. A conserved disulfide bond
between Cys246 of A (or C)-chain and Cys8 of B (or D)-
chain holds the two chains tightly as shown in figure 1.
Table 1: Crystal data and refinement statistics for AAG.
Crystal ID AAG
Agglutinin A-Chain Residues 1-250
Agglutinin B-Chain Residues 5-267
Agglutinin C-Chain Residues 1-250
Agglutinin D-Chain Residues 5-267
X-ray wavelength (Å) 1
Crystal system tetragonal
Space group name P41212
Cell length a (Å) 137.050
Cell length b (Å) 137.050
Cell length c (Å) 214.424
Cell volume (Å^3) 4027462.2






Crystal size (mm^3) 0.30 × 0.30 × 0.25





Averaged R_sym (outer sell) 0.0727 (0.3600)
Averaged I/FI (outer sell) 11.9 (1.8)
Completeness (%) (outer sell) 99.1 (98.1)Cheng et al. Journal of Biomedical Science 2010, 17:34
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An asymmetric unit of AAG crystal contains four peptide
chains, AB- and non-crystallographical-symmetric
related CD-chains, as shown in figure 1. The two het-
erodimers AB and CD are bonded together through
hydrogen bonds by using the water molecules between
them as intermediate bridges. They are identical except
two N-acetylglucosamines (NAGs) are found in AB-
chains, and one in CD-chains. An AAG molecule is a
tetramer, consisting of AB (or CD) and symmetry-related
A'B' (or C'D').
Structure of the AAG A(or C)-chain
The AAG A(or C)-chain was divided into three folding
domains γ1,γ2, and γ3 by reference to the description of
the abrin-a A-chain [31], and to the CATH database [44].
Figure 2 shows the sequence and secondary structures,
while figure 3 shows the cartoon of the three domains.
Domain γ1 (figure 3(a)), composed of residues 1 to 111,
consists of two β-sheets and two α-helices. The former β-
sheets include six strands of adefgh (sheet 1) and two
strands of bc (sheet 2), while the latter α-helices include
helix A of residues 13 to 27, and helix B of residues 91 to
96. The strands and helices alternate in the order aAb-
cdefgBh. In sheet 1, the first strand, a, of the β-sheet 1 and
the last strand, h, lie parallel to the neighboring strands, d
and g, respectively. The four central strands of the β-
sheet 1, d to g, are anti-parallel. In sheet 2, strands b and c
are anti-parallel. The main differences between domains
γ1 of AAG and abrin-a occurred in N-terminal. The N-
terminal of the AAG A-chain is one residue shorter than
that of the abrin-a A-chain and the first five terminal resi-
dues are different. Domain γ2, residues 112 to 195, is
dominated by five helices (figure 3(b)), C to G. Helix C,
composed of residues 112 to 119, D, residues 120 to 141,
E, residues 147 to 166, F, residues 168 to 180, and G, resi-
dues 188 to 194. Helix C is 3 residues longer than that of
abrin-a, due to replacement of Thr114 and Arg118 in
abrin-a by Asp113 and Lys117 in AAG. Other secondary
structures in domain 2 are almost conserved in abrin-a
and AAG. Domain γ3 (figure 3(c)), composed of residues
198 to 250, contains two helices, H, residues 197 to 206
and I, residues 234 to 238, and a β-sheet of two anti-par-
allel strands, i and j, situated in the order HijI, and a ran-
dom coil in the C terminal part. The last 8 residues in the
C terminal of A-chain are severely disordered, and we
could not determine their structures by X-ray diffraction.
Structure of the AAG B (or D)-chain
The overall folding of the AAG B (or D)-chain and the
abrin-a B-chain is very similar, as shown in figure 1, and
the disulfide bond connecting A- and B-chains is con-
served. The α-carbon traces of their N terminal, residues
1 to 12 differ significantly. The first four residues in the
Redundancy (outer sell) 4.1 (3.6)
Resolution range of 
collection (Å)
2.47 ~ 30.0
Resolution range of 
refinement (Å)
2.6 ~ 19.88
R_cryst (outer sell) 0.204 (0.211)
R_free (outer sell) 0.236 (0.256)
No. of protein atoms 8062
No. of water molecules 169
No. of NAG atoms 42
rms deviation from ideal 
bond length (Å)
0.009
rms deviation from ideal 
bond angle (º)
1.3













Ramachandran plot [50] (% 
of residues)
in the most favored 
regions (A, B, L)
81.7
in the additionally 
allowed regions 
(a, b, l, p)
18.3%
Table 1: Crystal data and refinement statistics for AAG. Cheng et al. Journal of Biomedical Science 2010, 17:34
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Figure 1 Comparison of AAG with abrin-a (green) molecule. The α-carbon backbone of abrin-a AB-chains are superimposed on that of the AAG 
molecule using least-squares analysis. A P41212 asymmetric unit of AAG contains an AB-chain and a CD-chain. Disulphide bonds are plotted as big 
yellow balls. This figure was generated by O program (Jones et al., 1991).
Figure 2 AAG A (or C)-chain sequence & secondary structures. The symbol of "arrow" represents a β-strand, "spiral" represents an α-helix, "dot" 
represents missing residues, and the alphabets a, b, A, etc, denote the corresponding secondary structures in figure 3.Cheng et al. Journal of Biomedical Science 2010, 17:34
http://www.jbiomedsci.com/content/17/1/34
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Figure 3 Three domains of AAG A (or C)-chain: (a) domain γ1, (b) domain γ2, (c) domain γ3. These figures were generated by O program (Jones 
et al., 1991).Cheng et al. Journal of Biomedical Science 2010, 17:34
http://www.jbiomedsci.com/content/17/1/34
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AAG B (or D)-chain are severely disordered, and we
could not determine their structures by X-ray diffraction.
The AAG B-chain is composed of two homologous
d o m a i n s ,  δ 1  a n d  δ 2 ,  m a i n l y  f o r m e d  b y  β - s h e e t s  a n d
loops. Figure 4 shows the sequence and secondary struc-
tures, while figure 5 shows the cartoon of the two
domains. Domain δ1 (figure 5(a)), composed of residues
5 to 140, consists of five anti-parallel β-sheets, one 4-
stranded (of ijkl), one 3-stranded (of aef), and three 2-
stranded (strands bm, cd, and gh respectively), and one α-
helix of residues 90 to 94. The strands and helices alter-
nate in the order abcdefghAijklm. Domain δ2 (figure
5(b)), composed of residues 141 to 267, consists of four
anti-parallel β-sheets, including two 4-stranded (strands
ynqr and uvwx respectively), and two 2-stranded (strands
op and st) sheets.
Each domain of δ1 and δ2 contains two intra-domain
disulfide bonds (Cys25-Cys44, Cys68-Cys85, Cys156-169,
and Cys195-Cys212), which are conserved in abrin-a.
Two NAGs are found in B-chain, but only one presents in
D chain. The NAGs are bound to B-Asn100 (figure. 6), B-
Asn140, and D-Asn140 respectively. The bond length
between NAG and Asn140 is 1.45 Å.
Structure of Active site
The active site is exactly the cleft formed by the intersec-
tion of all 3 domains in AAG A (or C)-chain. The location
of the active site region of the AAG A (or C)-chain is
shown in figure 7(a), and enlarged in figure 7(b). Five
invariant residues (Tyr73, Tyr112, Glu163, Arg166 and
Trp197) and five conserved residues (Asn71, Arg123,
Gln159, Glu194 and Asn195) are located in the active site
cleft. The alignment of the amino acid sequences shows
that all five invariant residues in the active site of abrin-a
are absolutely conserved throughout the wide range of
ribosome-inactivating proteins [19,45]. The similarity of
active site structures between abrin-a and AAG shows in
figure 7(b) that they may work in the same way, but could
not explain the less than half biochemical activity of
AAG. We try to answer this question by the 28SRNA
docking study.
Quaternary Structure of AAG
An AAG molecule is a hetero-tetramer (as shown in fig-
ure 8) contains two subunits, ABA'B' (or CDC'D'), stabi-
lized by mainly hydrophilic and little hydrophobic forces.
The two subunits are in equivalent positions of the space
group P41212. The transformation from AB to A'B' is (x, y,
z) to (1-y, 1-x, 0.5-z), while CD to C'D' is (x, y, z) to (y, x,
1-z). The hydrophilic interaction is dominated by inter-
subunit hydrogen bonds, as listed in table 2. These hydro-
gen bonds belong to residues of domains γ2 and γ2'. Since
the γ2 domain is almost made up with α-helices, which
hydrophobic side-chains are buried inside, hydrophobic
forces contribute little to the stabilization of quaternary
structure of AAG. The total buried surface area is 9360
for ABA'B' and 9460 for CDC'D' interfaces. The gain in
hydrophobic energy is -68 KCal/Mol for ABA'B' and -72
KCal/Mol for CDC'D'. The buried surface and hydropho-
bic energy are calculated by Protein interfaces, surfaces
Figure 4 AAG B (or D)-chain sequence & secondary structures. The symbol of "arrow" represents a β-strand, "spiral" represents an α-helix, "dot" 
represents missing residues, and the alphabets a, b, A, etc, denote the corresponding secondary structures in figure 5.Cheng et al. Journal of Biomedical Science 2010, 17:34
http://www.jbiomedsci.com/content/17/1/34
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Figure 5 Two domains of AAG B (or D)-chain: (a) domain δ1, and (b) domain δ2. These figures were generated by O program (Jones et al., 1991).Cheng et al. Journal of Biomedical Science 2010, 17:34
http://www.jbiomedsci.com/content/17/1/34
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Figure 6 Electron density of the NAG (red) near B 100Asn using the (2Fo - Fc) map contoured at 2.0 F. This figure was generated by O program 
(Jones et al., 1991).
Figure 7 Three domains of AAG A (or C)-chain are drawn as ribbons. (a) Gray purple and green indicate domain γ1 and green indicate domain 
γ1 γ2 γ2 and γ3 respectively. Active site residues are drawn in red. (b) Active Site comparison of abrin-a (red) and γ3 respectively. Active site residues 
are drawn in red. (b) Active Site comparison of abrin-a (red) AAG A-chain (black) AAG A-chain (black) and AAG C-chain (blue). These figures were gen-
erated by O program (Jones et al. and AAG C-chain (blue). These figures were generated by O program (Jones et al. 1991) and UCSF Chimera [32].Cheng et al. Journal of Biomedical Science 2010, 17:34
http://www.jbiomedsci.com/content/17/1/34
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Figure 8 Ribbon presentation of AAG quaternary structure: Red residues indicate the active site location. Purple and green residues consti-
tute inter-subunit hydrogen bonds. Domain γ2s are drawn in brown. This figure was generated by O program (Jones et al., 1991).
Table 2: Hydrogen bonds between inter-subunit with symmetry-related AA' and CC' chains.
Donor Acceptor D....A (A) Donor Acceptor D....A (A)
A Gln 121 NE2 A'Gln121 OE1 2.85 A Gln121 NE2 A'Gln121 OE1 2.85
A Arg 25 NH1 A'Glu148OE2 2.77 A Arg125NH1 A'Glu148OE2 2.77
A Leu 130 N A'Glu131OE2 3.15 A Leu 130 N A'Glu131OE2 3.15
A Arg 134 NH2 A'Asn 180 O 2.86 A Arg 134 NH2 A'Asn 180 O 2.86
A Arg 134 NE A'Asn 181 O 3.06 A Arg 134 NE A'Asn 181 O 3.06
A Gln 135 NE2 A'Ser 127 OG 3.07 A Gln 135 NE2 A'Ser 127 OG 3.07
C Gln 121 NE2 C'Ser 145 O 2.75 C Gln 121 NE2 C'Ser 145 O 2.75
C Ser 127 OG C'Gly 143 N 2.95 C Ser 127 OG C'Gly 143 N 2.95
C Arg 134 NR C'Tyr57 OH 2.64 C' Arg 134 NR C Tyr57 OH 2.64
C Gln 135 NE2 C'Gln135 O 2.94 C' Gln 135 NE2 C Gln135 O 2.94
C Ser 145 N C'Gln121OE1 2.59 C' Ser 145 N C Gln121 O 2.59Cheng et al. Journal of Biomedical Science 2010, 17:34
http://www.jbiomedsci.com/content/17/1/34
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Figure 9 (a) The docking model (blue) and the original 28SRNA (yellow). A4324 was artificially manipulated. (b) The docking of 28SRNA (blue) on 
abrin-a A-chain (purple) and AAG A-chain (yellow). (c) G4323 (red) of 28SRNA docking model (blue), is hydrogen-bonded with Asn2000 of abrin-a A-
chain (purple), but has no interaction with corresponding Pro199 of AAG A-chain (yellow).
A
B
CCheng et al. Journal of Biomedical Science 2010, 17:34
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and assemblies service PISA at European Bioinformatics
Institute http://www.ebi.ac.uk/msd-srv/prot_int/
pistart.html[46].
Docking of 28SRNA to AAG and Abrin-a
As pointed out in the mutagenesis study [21], Pro199 in
A- (or C-) chain of AAG impair the activity of protein
synthesis inhibition. Bagaria et al., [25] suggested that the
less toxic nature is because of the fewer interactions
involved with the substrate adenine. From our docking
study, we found Asn200 of abrin-a may form a critical
hydrogen bond with G4323 of 28SRNA, while corre-
sponding Pro199 of agglutinin is a non-extended residue
bound with the cleft in a more compact complementary
relationship as shown in figure 9(c). This may explain the
lower toxicity of agglutinin, despite of similarity in sec-
ondary structure and the activity cleft of two RIPs. The
docking model of 28SRNA was artificially deformed at
the ribose sugar of A4324 from the X-ray crystal struc-
ture 430D [47], as shown in figure 9(a), so that A4324 of
28SRNA can overlap with the adenine of the ricin-ade-
nine complex, 1IFS [48]. Figure 9(b) shows deformed
model fit well in the active clefts of both abrin-a and
AAG. Figures 9(a), 9(b) and 9(c) were generated with
UCSF Chimera [49].
We want to explore whether the difference in the criti-
cal residue, bring any change in structure. However, we
could not observe significant main-chain distortion due
to the difference in the 200 residue on higher resolution
structure. Hence, the reason for the lower toxicity of
agglutinin than abrin-a might be due to the deformation
f r o m  i n a c t i v e  t o  a c t i v e  s t a t e  o f  a b r i n  d e p e n d s  o n  t h e
meta-stable huge helix, composed of helix h and helix g.
The mutation of Asn200 to Pro200 destroys the mecha-
nism.
Conclusion
We have successfully solved the structure of 120 kDa het-
erotetramer agglutinin AB and CD chains, and reduced
the R-factor to 20.4% at 2.6 Å resolution data. Ten disul-
fide bonds, three N-acetylglucosamines, and 169 water
molecules were found in the successive (2Fo-Fc) map. 22
hydrogen bonds between A (or C)-chain and symmetry-
related A' (or C') were found. Water molecules were not
found in the Bagaria's paper and no subsequent hydrogen
bond lengths were listed based on their lower resolution
structure [25]. Docking study revealed that due to
Pro199, agglutinin is unable to form a critical hydrogen
bond with G4323 of 28SRNA, which is found in the dock-
ing result of abrin-a. This may explain the lower toxicity
of agglutinin than abrin-a, despite of similarity in second-
ary structure and the activity cleft of two RIPs.
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